Skip to main content
. 2015 Mar 11;59(4):1983–1991. doi: 10.1128/AAC.04641-14

TABLE 1.

MICs of different antibiotics against clinical isolates of A. baumannii

Isolate MIC (μg/ml)a
Ampicillin Ceftazidime Levofloxacin Minocycline Polymyxin B
1775 2 12 0.125 0.125 0.064
1776 2 12 0.125 0.125 0.5
1777 2 8 0.125 0.125 4
1788 16 64 >32 8 0.75
1789 12 48 >32 12 1
1790 16 96 8 4 0.5
1791 24 128 8 1.5 0.75
1792 64 64 8 2 0.75
1793 32 64 12 2 0.5
1794 32 96 6 1.5 0.64
1795 14 96 4 1.5 0.125
1796 128 96 4 2 0.125
1797 256 128 4 2 0.38
a

The antibiotic class, target, dose range tested, and susceptibility breakpoints for the tested drugs were as follows: ampicillin, β-lactam, cell wall, 0.016 to 256 μg/ml, susceptibility at ≤8 μg/ml and resistance at ≥32 μg/ml; ceftazidime, β-lactam, cell wall, 0.016 to 256 μg/ml, susceptibility at ≤16 μg/ml and resistance at ≥64 μg/ml; levofloxacin, fluoroquinolone, topoisomerases, 0.002 to 32 μg/ml, susceptibility at ≤2 μg/ml and resistance at ≥8 μg/ml; minocycline, tetracycline, protein synthesis, 0.016 to 256 μg/ml, susceptibility at ≤4 μg/ml and resistance at ≥16 μg/ml; polymyxin B, polypeptide, outer membrane, 0.064 to 1,024 μg/ml, susceptibility at ≤2 μg/ml and resistance at ≥8 μg/ml. Bold numbers indicate resistance.